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computational	 avenues—real-	time	 computational	 analysis	 of	 genetic	 data,	 phylody-















Karabatsos,	 Dalrymple,	 Shope,	 &	 Porterfield,	 1989).	 More	 than	 70	
flaviviruses	 have	 so	 far	 been	 identified	 (Kuno,	 Chang,	 Tsuchiya,	
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1.2 | Dengue evolution
Observations	were	made	in	the	late	1970s	of	dengue-	like	viruses	and	
respective	animal	 reservoirs	 in	Asia	and	West	Africa	 (Aiken	&	Leigh,	






the	 oldest,	 estimated	 to	 be	 approximately	 1,000	years	 old	 (Twiddy,	
Holmes,	&	Rambaut,	2003;	Weaver	&	Vasilakis,	2009),	roughly	corre-
sponding	to	some	of	the	first	reports	of	dengue-	like	illnesses	(Vasilakis	
&	Weaver,	 2008;	Tang	 et	al.,	 2010;	Weaver	 &	Vasilakis,	 2009).	The	
genetic	distance	between	currently	circulating	serotypes	is	likely	a	by-	







identified	 genetic	 subgroups	or	 lineages,	 commonly	denominated	
as	dengue	genotypes	(Tang	et	al.,	2010;	Weaver	&	Vasilakis,	2009).	
Notably,	 the	 overall	 amino	 acid	 sequence	 similarity	 among	 geno-
types	 is	generally	above	90%	(Holmes	&	Twiddy,	2003;	Leitmeyer	
et	al.,	 1999),	 whereas	 between	 serotypes,	 it	 can	 range	 between	
60%	 and	 80%	 (Irie,	 Mohan,	 Sasaguri,	 Putnak,	 &	 Padmanabhan,	
1989;	 Rothman,	 2011).	 Although	 RNA	 viruses	 generally	 pres-
ent	 rapid	 evolution	 and	 accumulation	 of	 diversity	 occurring	 at	 a	
similar	 time-	scale	 as	 their	 host’s	 ecological	 dynamics	 (Grenfell,	
Pybus,	Gog,	Wood,	&	Daly,	2004),	studies	have	demonstrated	that	
strong	 purifying	 selection	 dominates	 DENV’s	 recent	 evolution	
(Bennett,	Holmes,	Chirivella,	Rodriguez,	&	Beltran,	2003;	Holmes,	
2003;	Holmes	&	Twiddy,	2003;	Weaver	&	Vasilakis,	2009;	Zhang,	
Mammen,	 Chinnawirotpisan,	 Klungthong,	 &	 Rodpradit,	 2005).	 A	
prevailing	hypothesis	 is	that	the	virus	has	evolved	to	replicate	ef-
ficiently	 in	 both	 the	 vertebrate	 and	 arthropod	 hosts	 (Filomatori,	
Carballeda,	Villordo,	Aguirre,	&	Pallarés,	2017),	expressing	a	com-
promise	genome	 in	which	most	amino	acid	changes	are	expected	
to	 be	 deleterious	 and	 selectively	 removed	 from	 the	 population	
(Holmes,	 2003;	 Holmes	 &	 Twiddy,	 2003;	 Weaver	 &	 Vasilakis,	
2009).	 The	 lack	 of	 recombination,	 supported	 by	 rare	 reports	 on	
naturally	 occurring	 recombinants	 (Waman,	 Kolekar,	 Ramtirthkar,	
Kale,	&	Kulkarni-	Kale,	2016;	Weaver	&	Vasilakis,	2009),	 is	further	






vectors:	Aedes aegypti and Ae. albopictus.	 Intercontinental	changes	 in	
the	second	half	of	the	20th	century,	in	particular	the	post-	World	War	
II	boom	in	urbanization	and	globalization,	have	facilitated	the	introduc-
tion	 and	 establishment	 of	 dengue’s	 two	 principal	 mosquito	 vectors	
into	 many	 major	 urban	 and	 peri-	urban	 settings	 and	 resulted	 in	 the	
worldwide	establishment	of	endemic	transmission	cycles	(i.e.,	between	








nonhuman	 primates	 and	 arboreal	 Aedes	 species.	 Rural	 populations	





ity,	weak	surveillance	and	lack	of	peridomestic	vectors	(Ae. aegypti and 
Ae. albopictus).
1.4 | Dengue epidemiology
The	epidemiological	 picture	 of	 dengue	 across	 the	world	 is	 variable.	
While	hyperendemicity	is	classically	associated	with	South-	East	Asia,	
the	 21st	 century	 has	 witnessed	 the	 endemic	 establishment	 of	 the	
virus	 in	 South	 and	 Central	 America	 (Brathwaite	 Dick,	 San	 Martín,	
Montoya,	 del	 Diego,	 &	 Zambrano,	 2012;	 San	 Martín,	 Brathwaite,	
Zambrano,	Solórzano,	&	Bouckenooghe,	2010).	Dengue	has	also	re-
cently	emerged	 in	 the	United	States,	with	 repeated	but	 so	 far	 self-	
contained	outbreaks	in	Florida	and	Texas	(Guzman,	Halstead,	Artsob,	
Buchy,	&	Farrar,	2010;	Radke,	Gregory,	Kintziger,	 Sauber-	Schatz,	&	
Hunsperger,	 2012;	 Thomas,	 Santiago,	 Abeyta,	 Hinojosa,	 &	 Torres-	




2010;	Gjenero-	Margan,	 Aleraj,	 Krajcar,	 Lesnikar,	 &	 Klobučar,	 2011;	
Lourenço	&	Recker,	2014).
Poor	 surveillance,	 no	 official	 reporting	 to	 the	WHO	 (Jaenisch,	
Junghanss,	Wills,	Brady,	&	Eckerle,	2014)	and	the	high	prevalence	




(Bin	 Ghouth,	 Amarasinghe,	 &	 Letson,	 2012),	 Sudan	 (Seidahmed,	
Hassan,	Soghaier,	Siam,	&	Ahmed,	2012)	and	Madagascar	(Schwarz,	
Girmann,	 Randriamampionona,	 Bialonski,	 &	Maus,	 2012).	 In	 2004	
and	2009,	epidemics	occurred	 in	the	 isolated	populations	of	Cape	
Verde	 (Franco,	 Di	 Caro,	 Carletti,	 Vapalahti,	 &	 Renaudat,	 2010),	
Mauritius	 islands	 (Issack,	 2010)	 and	 Reunion	 island	 (Larrieu,	
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Dehecq,	 Balleydier,	 Jaffar,	 &	 Michault,	 2012),	 and	 a	 major	 epi-
demic	in	Pakistan	took	place	in	2013	(Kraemer,	Perkins,	Cummings,	
Zakar,	&	Hay,	2015;	Khan,	Khan,	&	Amin,	2016).	Together	with	the	
widespread	 presence	 of	Ae. aegypti and Ae. albopictus,	 this	would	













dengue	 serotypes	were	 only	 recently	 introduced	 are	more	 likely	 to	
show	wave-	like,	increasing	patterns	of	incidence	(Figure	1c,f).	Spatial	
heterogeneities	 are	also	 common	 in	 reported	data,	highlighting	 that	
the	 success	 of	 dengue	viruses	 can	 be	 dictated	by	 numerous	 demo-
graphic	and	ecological	determinants	(Figure	1f;	Adams	&	Kapan,	2009;	
Beebe,	 Cooper,	 Mottram,	 &	 Sweeney,	 2009;	 Campbell,	 Haldeman,	





with	 periods	 of	 8–10	years	 (Figure	1d,e;	 Adams,	 Holmes,	 Zhang,	
Mammen,	 &	Nimmannitya,	 2006;	 Bennett	 et	al.,	 2010;	 Lourenço	 &	
Recker,	2013;	Nisalak	et	al.,	2003).	Whereas	 incidence	dynamics	are	
thought	 to	 be	 driven	 by	 a	 complex	 interplay	 of	 local	 factors,	 from	
the	abundance	of	susceptible	humans,	climate	and	viral	traits,	to	the	





directly	 influence	 the	 qualitative	 properties	 of	 serotype	 cyclical	 be-
haviour,	which	seems	to	be	a	universal	feature	of	dengue	epidemiology.
1.5 | Human infections, immunity and disease
Primary	infections	in	humans	with	any	of	the	four	serotypes	are	gen-








forms	 of	 disease—dengue haemorrhagic fever	 (DHF)	 or	dengue shock 
syndrome	 (DSS)—with	manifestations	 of	 circulatory	 failure,	 vascular	
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Flaviviruses	 are	 known	 to	 induce	 the	 phenomenon	 of	 original 
antigenic sin	 (OAS)	 (Francis,	 1960),	 in	 which	 B-	cell	 clones	 sequen-
tially	 challenged	 by	 viruses	 of	 the	 same	 family	 initially	 respond	 by	
synthesizing	 antibodies	 with	 higher	 affinity	 to	 a	 previous	 infecting	
virus	 (Halstead,	 Rojanasuphot,	 &	 Sangkawibha,	 1983).	 This	 creates	
a	cascade	of	regulatory	changes	that	facilitates	expression	and	syn-
thesis	of	pro-	inflammatory	cytokines	and	induces	a	positive	feedback	
that	 increases	 the	 rate	 of	 intracellular	 infection,	 leading	 to	 higher	
viraemia	 levels	 and	worse	 clinical	 outcomes	 (Beltramello,	Williams,	










Generally,	 cellular	 immune	 responses	 (T	 cell)	 to	DENV	 are	 seen	
to	 cover	 most	 of	 the	 viral	 proteins	 (Duangchinda,	 Dejnirattisai,	
Vasanawathana,	 Limpitikul,	 &	 Tangthawornchaikul,	 2010;	 Rothman,	
2011),	 but	with	 a	 particular	 dominant	 signal	 for	NS3	 (Duangchinda	
et	al.,	 2010),	 which	 represents	 only	 ≈20%	 of	 DENV	 amino	 acid	
coding	 sequence	 (Rothman,	 2011).	 T-	cell	 clones	 can	 be	 serotype	
cross-	reactive,	 sero-	specific	or	even	 strain-	specific	 (i.e.,	within	 sero-
type;	 Bashyam,	 Green,	 &	 Rothman,	 2006;	Mangada,	 Endy,	 Nisalak,	
Chunsuttiwat,	&	Vaughn,	2002;	Rothman,	2011;	Sierra,	García,	Pérez,	
Morier,	 &	 Rodríguez,	 2002;	 Ubol	 &	 Halstead,	 2010).	 The	 cross-	
reactivity	 is	 not	 surprising,	 however,	 given	 the	 ≈70% amino acid 
identity	between	DENV1	and	DENV4	(Rothman,	2011).	OAS	in	T-	cell	
responses,	 including	 inflammation	 and	 cytokine-	induced	 alteration	
of	vascular	permeability	 (Rothman,	2011),	have	also	been	described	














between	 such	 factors	 is	 often	 difficult	 (Rothman,	 2011),	 although,	








fecting	 serotype	 (homologous	 immunity)	 (but	 see	 (Forshey,	 Reiner,	
Olkowski,	Morrison,	&	Espinoza,	2016;	Waggoner,	Balmaseda,	Gresh,	
Sahoo,	&	Montoya,	2016)	for	possible	incomplete	protection).	A	period	
of	 6–36	months	 of	 temporary	 cross-	protective	 immunity	 to	 all	 sero-
types	 has	 also	 been	 suggested	 after	 recovery	 (see	 e.g.,	 Sabin,	 1952;	
Reich,	Shrestha,	King,	Rohani,	&	Lessler,	2013),	although	 it	 is	still	un-
certain	whether	 this	 form	of	 immunity	 solely	protects	 against	 clinical	
disease	 or	 completely	 prevents	 infection	 (Bhoomiboonchoo,	 Nisalak,	
Chansatiporn,	 Yoon,	 &	 Kalayanarooj,	 2015;	 Anderson	 et	al.,	 2014;	




























It	 is	broadly	recognized	that	 immune	competition	can	act	 to	de-
synchronize	antigenically	diverse	pathogens,	such	as	dengue,	malaria	
(Plasmodium falciparum)	or	the	influenza	A	virus,	and	cause	nonlinear	
or	 chaotic	 oscillations	 not	 too	 dissimilar	 to	 the	 observed	 epidemio-
logical	 patterns	 of	 dengue.	 For	 dengue,	 competition	 between	 sero-
types	 can	 be	 driven	 by	ADE	 of	 secondary,	 heterologous	 infections	
or	 through	 (temporary	or	permanent)	cross-	immunity.	Both	types	of	
interactions	are	assumed	to	affect	the	transmissibility	of	subsequent	
infections,	 leading	 to	 frequency-	dependent	 selection	 that	 has	 been	
demonstrated	to	generate	oscillatory	behaviour	and	further	facilitate	
serotype	persistence	(Schwartz,	Shaw,	Cummings,	Billings,	&	McCrary,	
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2005;	 Ferguson,	 Anderson,	 &	 Gupta,	 1999;	 Cummings,	 Schwartz,	
Billings,	 Shaw,	 &	 Burke,	 2005;	 Aguiar,	 Kooi,	 &	 Stollenwerk,	 2008;	
Wearing	&	Rohani,	2006;	Adams	&	Boots,	2006;	Hu,	Thoens,	Bianco,	
Edlund,	&	Davis,	2013).
With	 regard	 to	ADE,	 initial	 criticism	 concerning	 the	 level	 of	 en-
hancement	 required	 for	 serotype	 desynchronization	 could	 be	 coun-
tered	by	also	assuming	enhancement	in	the	susceptibility	to	secondary	
infections	 (see	e.g.,	 (Recker,	Blyuss,	 Simmons,	Hien,	&	Wills,	2009)).	
Importantly,	 however,	 empirical	 evidence	 supporting	 a	 universal	 in-
crease	 in	 the	 transmission	 potential	 of	 secondary	 infections	 is	 still	
lacking.	That	is,	while	the	ADE	phenomenon	has	been	shown	both	in	
in	vitro	and	 in	vivo	studies	 (Halstead	et	al.,	2010;	Dejnirattisai	et	al.,	







2008;	 Wearing	 &	 Rohani,	 2006).	 Recent	 studies	 on	 prospective	
cohorts	 have	 found	 that	 shorter	 time	 periods	 between	 sequen-
tial	 infections	 are	 associated	with	 some	 degree	 of	 clinical	 protec-
tion	(Anderson	et	al.,	2014;	Montoya,	Gresh,	Mercado,	Williams,	&	
Vargas,	2013).	However,	apart	from	a	single	human	study	conducted	
in	 the	1950s	 (Sabin,	1952),	experimental	support	 for	both	the	na-
ture	 and	duration	of	 cross-	immunity	 is	 still	 lacking.	Consequently,	
there	 is	 no	 broad	 consensus	 about	 the	 protective	 efficacy	 of	 the	
observed	cross-	reactivity	between	dengue	serotypes	and	whether	




It	 is	worth	noting	 that	 some	of	 the	 controversies	 surrounding	
serotype	 immune	 interactions	 and	 their	 effects	 on	 the	 epidemio-
logical	dynamics	of	dengue	are	partially	consequences	of	the	actual	
modelling	 frameworks	 themselves.	 That	 is,	 deterministic	 models	
based	 on	mass-	action	 principles,	which	 comprise	 the	majority	 of	
mathematical	models	found	in	the	published	 literature,	require	an	
interaction	 term	 in	 order	 to	 desynchronize	 the	 serotypes	 and	 to	
exhibit	 dengue’s	 characteristic	 multi-	annual	 incidence	 patterns.	
Stochastic,	 and	 in	 particular	 individual-	based,	models	 do	 not	 rely	
on	 this	 assumption	 to	 generate	 epidemiological	 time	 series	with	
such	 properties.	 The	 contrasting	 dynamic	 behaviour	 is	 driven	 by	
the	 amplification	 of	 stochastic	 effects	 at	 the	 individual-	level	 (de-
mographic	 stochasticity),	 which	 keeps	 each	 serotype/strain	 in	 a	
transient	 regime	 rather	 than	approaching	 the	expected	determin-
istic	 equilibrium	 even	 in	 the	 absence	 of	 explicit	 desynchronizing	






2  | CHALLENGES AND OPPORTUNITIES IN 
COMPUTATIONAL RESEARCH
The	zoonotic	origin,	 separate	endemic	and	sylvatic	 transmission	cy-





















































so	 far	 limited	our	capacity	 to	 link	 important	population	genetic	and	
ecological	 observations	with	 the	pathogen’s	 epidemiological	 behav-
iour	within	a	single	framework.	In	sharp	contrast	to	other	major	viral	
pathogens,	 such	 as	 the	 influenza	A	 virus	 or	 the	 human	 immunode-
ficiency	virus	 (HIV),	evolutionary	 frameworks	do	not	 feature	promi-
nently	in	dengue’s	modelling	literature,	with	the	field	of	phylogenetics	
so	far	dominating	evolutionary	approaches.
In	 general,	 the	 continuing	 geographical	 and	 epidemic	 expansion	
of	dengue’s	genetic	variants	and	mosquito	vectors,	and	the	failure	to	
prevent	 the	 introduction	 and	 establishment	 of	 sustained	 transmis-
sion	across	 the	globe,	call	 for	a	 renewed	 focus	and	advancement	 in	
computational	approaches.	In	the	context	of	dynamic	modelling,	the	
literature	has	been	dominated	by	frameworks	based	on	ordinary	dif-






on	 this	 biological	 system,	 and	with	 the	 aim	 of	 linking	 evolutionary,	
ecological	and	epidemiological	aspects	as	well	as	to	expand	on	classic	
modelling	assumptions,	we	here	propose,	discuss	and	exemplify	a	few	




2.1 | Real- time collection and computational 




2009;	 Vasilakis,	 &	 Weaver,	 2008).	 At	 present,	 the	 distribution	 of	
DENV	 serotypes	 results	 from	 a	 combination	 of	 strong	 population	
structure	and	gene	flow	across	geographical	regions.	South-	East	Asia	









dance	of	 the	Ae. aegypti	mosquito	 (Kraemer,	Sinka,	Duda,	Mylne,	&	
Shearer,	2015)	and	an	increasingly	well-	connected	mobility	network	
that	 facilitates	the	movement	of	 infected	hosts	and	vectors	 (Nunes	
et	al.,	 2014;	 Wesolowski,	 Qureshi,	 Boni,	 Sundsøy,	 &	 Johansson,	
2015).







complicated	by	 the	 circulation	of	pathogens	 that	 cause	 similar	 clin-
ical	 symptoms	 to	 DENV	 infection,	 such	 as	 the	 chikungunya	 virus	
(CHIKV)	 and	 ZIKV,	 and	 may	 thus	 hamper	 accurate	 descriptions	 of	


































genome	 sequences.	 Sequencing	during	epidemics	 is	 even	becoming	
an	increasing	trend,	which	is	important	for	our	understanding	on	how	
particular	genotypes	associated	with	increased	virulence	may	be	gen-
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With	the	real-time genomic epidemiology revolution	(Gardy,	Loman,	
&	 Rambaut,	 2015),	 new	 and	 complementing	 insights	 (to	 clinical	 re-
ported	case	data)	are	expected	to	provide	unique	information	about	
the	macro-	and	microscale	process	shaping	viral	dynamics.	Statistical	











increased	 time	 and	 spatial	 resolution	will	 allow	 future	 phylogenetic	
and	modelling	studies	to	further	evaluate	the	relative	contribution	of	
short-	and	long-	distance	mobility.
It	 may	 seem	 that	 these	 recently	 established	 approaches	 and	




endemicity.	However,	major	 gaps	 in	our	 knowledge	 still	 exist	 in	 the	
context	of	DENV,	 sustained	by	 the	 insufficiency	of	 clinical	 reported	























nections,	 unifying	 key	 observations	 across	 biological	 scales	 within	
a	 single	 framework	 known	 as	 phylodynamics	 (Grenfell	 et	al.,	 2004;	






Dengue	virus	 is	 a	 surprisingly	 conserved	RNA	virus	 (Choudhury,	
Lott,	Banu,	Cheng,	&	Teo,	2015;	Lequime,	Fontaine,	Ar	Gouilh,	Moltini-	
Conclois,	 &	 Lambrechts,	 2016;	Thai,	Henn,	 Zody,	Tricou,	&	Nguyet,	
2012;	Amarilla,	de	Almeida,	Jorge,	Alfonso,	&	de	Castro-	Jorge,	2009;	
Holmes,	2003).	Even	though	its	serotypes	present	seemingly	compet-
itive	dynamics,	 similar	 to	 the	behaviour	of	antigenic	strains	of	other	




mission	models	have	offered	 insight,	but	have	so	 far	 failed	 to	 reach	
consensus	on	the	possible	biological	drivers	of	the	observed	dynamic	
behaviour.	 For	 other	 pathogens,	 such	 as	 influenza	A,	 phylodynamic	
transmission	models	have	allowed	to	filter	out	a	wide	range	of	hypoth-
eses	regarding	potential	drivers	(e.g.,	Bedford,	Suchard,	Lemey,	Dudas,	







and	phylogenetic	data,	 similar	 to	approaches	applied	 to	 influenza	A.	
This	approach	is	exemplified	in	Box	I,	where	we	extended	a	previously	





porary,	 serotype-	transcending	 immunity	 following	 recovery	 from	 in-
fection	(Box	I,	e–f).	With	this	approach,	the	phylogenetic	output	would	





Given	 seasonal	 epidemic	 troughs	 in	 endemic	 regions,	 possible	
mechanisms	 for	viral	 persistence	 are	 still	 open	 topics	 of	 discussion,	
in	particular	as	phylogenetic	studies	have	shown	that	the	lack	of	case	
















can	 be	 expected	 to	 behave	 differently,	 for	 example	 depending	 on	











tional	 input,	which	 follows	 an	 infinite-	sites	model	with	no	 recombination;	 all	mutations	 are	 assumed	 to	be	neutral;	 a	 burn-	in	period	of	
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In	a	broader	evolutionary	perspective,	drivers	of	key	observations	
on	 the	molecular	 evolution	 of	 dengue	 could	 also	 be	 studied	within	
these	frameworks.	For	 instance,	strong	purifying	selection	 is	consis-
tently	 reported	 in	 sequence	data,	 for	which	 it	 is	 generally	 accepted	
that	the	two-	host	 life	cycle	imposes	strong	evolutionary	constraints.	
Box	I	 (b)	 shows,	 however,	 that	 even	without	 explicit	 constraints	 on	
molecular	evolution	(e.g.,	deleterious	mutations),	negative	Tajima	D,	a	
proxy	for	purifying	selection,	is	self-	emergent.	As	such,	demographic	











to	 result	 in	 significant	 changes	 in	 disease	 incidence	 (Lourenço	 &	
Recker,	 2010).	While	 there	 are	 rare	 examples	 of	well-	described	 lin-













exist	 for	 these	observations	 (Choudhury	et	al.,	2015;	Lequime	et	al.,	
2016;	Thai	et	al.,	 2012).	By	allowing	parameterization	of	mutational	
input	 and	 quantification	 on	 how	 population-	level	 events	 modulate	
within-	host	genetic	diversity,	phylodynamic	models	could	help	make	











ation,	 emergence	 and	 spread	of	 escape	mutants	 could	 be	modelled	
within	phylodynamic	frameworks	such	as	the	one	presented	in	Box	I,	
given	 that	 individual	 mutations	 are	 already	 tracked.	Vaccination,	 as	
demonstrated	in	previous	work,	can	also	be	easily	included	(Lourenço	
&	Recker,	 2016;	 Flasche	 et	al.,	 2016).	 Parameterization	 on	 the	 effi-







Finally,	 as	described	 in	 the	previous	 section,	 real-	time	collection	
and	 analysis	 of	 genetic	 data	 will	 soon	 offer	 vast	 amounts	 of	 high-	
resolution	 data	 on	 population	 genetic	 measurements	 and	 phyloge-
netics,	 both	 in	 time	 and	 space.	 This	will	 fundamentally	 change	 our	
perspective	 and	 the	 number	 of	 empirical	 observations	 that	 can	 be	
used	to	validate	model	frameworks.	The	use	of	more	complex	mod-
elling	approaches,	such	as	individual-	based	models,	including	atypical	
dimensions	 such	as	detailed	 spatial	 scales	 (Box	II)	or	molecular	evo-
lution	 (Box	I),	will	not	only	be	a	valuable	path	of	research,	but	could	
indeed	 become	 necessary	 approaches	 to	 be	 able	 to	match	 the	 rich	
variety	of	observed	data	patterns	across	biological	scales.
2.3 | Within- host models
The	 vast	majority	 of	 dengue	models	 has	 focused	on	 viral	 dynamics	
at	 the	 population-	level.	 Given	 the	 importance	 that	 the	 within-	host	
processes	 (e.g.,	 ADE	 and	 cross-	immunity)	 play	 for	 both	 viral	 trans-
mission	 and	disease	pathology,	 it	 is	 thus	 surprising	 that	 just	 over	 a	
handful	 of	 studies	 have	 so	 far	 investigated	 viral	 dynamics	 at	 the	
within-	host	level	(Nuraini,	Tasman,	Soewono,	&	Sidarto,	2009;	Ansari	








The	 target	 cell	 population	 for	 DENV	 replication	 is	 still	 not	well	
characterized	 in	vivo,	although	 in	vitro	studies	strongly	suggest	 that	
monocytes,	dendritic,	 endothelial	 and	epithelial	 cells	 are	 among	 the	
preferential	 targets	of	 infection	 (Fernandez-	Garcia	et	al.,	2009;	Ubol	
&	 Halstead,	 2010;	 Dejnirattisai	 et	al.,	 2010;	 Katzelnick,	 Coloma,	 &	




There	 are	 two	 main	 known	 mechanisms	 of	 antibody	 action	 for	
viral	 clearance	 in	 dengue	 infection—antibodies	 can	 indirectly	 act	 to	
clear	infected	cells	via	antibody-	dependent	cell-	mediated	cytotoxicity	
(ADCC),	or	directly	by	neutralization.	A	data-	driven	study	by	Clapham	


























(a,	 b)	 The	 degree	 of	 connectivity	 between	 subpopulations	 has	 a	 strong	 effect	 on	 the	 epidemiological	 dynamics	 of	 dengue.	 (c,	 d)	Model	
	sensitivity	analysis	showing	the	relative	change	in	epidemiological	and	serotype-	specific	characteristics	depending	on	the	network’s	degree	
bias.	Each	point	is	the	result	of	50	model	runs	over	a	100-	year	period,	with	error	bars	depicting	the	standard	error.
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modelling	frameworks	(Gujarati	&	Ambika,	2014;	Nikin-	Beers	&	Ciupe,	
2015).	While	one	 study	concluded	 that	enhancing	antibodies	 (ADE)	
were	key	in	secondary	infections	(Gujarati	&	Ambika,	2014),	the	other	
study	suggested	instead	a	direct	decrease	of	overall	heterologous	viral	
clearance,	whereby	 cross-	reactive	 antibodies	 render	virions	 unavail-
able	 for	 further	binding	 and	 subsequent	 clearance	by	ADCC	 (Nikin-	
Beers	&	Ciupe,	2015).	 In	another	study,	the	question	about	the	role	
of	the	adaptive	and	innate	immune	responses	in	disease	severity	was	
addressed	 (Ben-	Shachar	 &	 Koelle,	 2014;	 Ben-	Shachar	 et	al.,	 2016).	
It	was	 shown	 that	 characteristic	 features	of	primary	 infection	 could	





2017).	 In	 line	with	previous	 results	by	Clapham	et	al.	 (2014),	 it	was	
































Another	 promising	 avenue	 is	 in	 the	 context	 of	 vaccination.	
Recently,	 the	 first	 dengue	 vaccine	 was	 licensed	 (Dengvaxia®)	 and	
many	others	are	in	advanced	trial	stages	(Schmitz,	Roehrig,	Barrett,	&	
Hombach,	2011;	Thomas	&	Endy,	2011;	Schwartz,	Halloran,	Durbin,	
&	 Longini,	 2015).	 For	 a	 good	 number	 of	 these,	 data	 will	 be	 made	
available	on	population-	level	efficacy	but	also	on	within-	host	markers	












between-	host	and	within-	host	dynamics	 could	be	 integrated	 in	uni-
fied,	multiscale	frameworks.	These	could	be	used	to	investigate	how	
assumptions	about	viral	dynamics	and	immune	kinetics,	together	with	








susceptible	 individuals	within	 that	population.	Under	 these	assump-







stochastic	 nature	 of	 infection	 events,	 for	 example,	 or	 through	 eco-
logical	and	demographic	heterogeneities,	cannot	be	captured	by	these	
models	and	require	a	different	approach	altogether.
Agent	 or	 individual-	based	 models	 offer	 a	 natural	 and	 intuitive	
way	 to	 account	 for	 these	 variations	 by	 keeping	 track	 of	 individual,	
probabilistic	 infection	 events	 in	 both	humans	 and	mosquito	vectors	
and	have	been	implemented	to	various	degrees	of	realism	and	model	
complexity.	As	an	example,	 spatial	 details	 can	be	 included	by	divid-
ing	the	population	into	smaller	subpopulations	arranged	in	a	rectan-




by	 adding	more	 realistic	 spatial	 arrangements	by	means	of	 complex	
networks	with	 nodes	 representing	 villages	 or	 cities	 and	 edges	 rep-










The	 inclusion	 of	 (every)	 minute	 detail	 comes	 at	 the	 cost	 of	
computational	feasibility	and	generalizability,	however.	That	is,	the	
computational	 demands	 imposed	 by	 an	 increase	 in	 model	 com-
plexity,	 due	 to	 the	 incorporation	 of	 more,	 and	more	 detailed	 in-
formation	 of	 individual-	level	 behaviours,	 can	 quickly	 exceed	 the	
capabilities	of	modern-	day	personal	computers	and	require	either	
very	 long	 run-	times	 or	 the	 implementation	 on	 high-	performance	
computer	 clusters.	 Furthermore,	 the	 limited	 availability	 of	 fine-	
scaled	data	necessary	to	parameterize	these	models	often	restricts	
their	use	 to	 the	 investigation	of	particular	 aspects	of	dengue	ep-
idemiology	 and	 mostly	 in	 one	 specific	 setting.	 Results	 obtained	
from	 these	 studies,	 although	highly	 informative	 for	 the	particular	
research	 question,	 are	 therefore	 not	 easily	 transferable	 to	 other	
epidemiological	or	geographical	settings.	This	then	implies	that	for	























et	al.,	 2015),	 mobility	 (Kraemer,	 Perkins	 et	al.,	 2015;	 Wesolowski	
et	al.,	 2015;	 Lemey	 et	al.,	 2014)	 or	 social/communication	 (Salathé,	











2008;	 Rodriguez-	Barraquer,	 Mier-	y	 Teran-	Romero,	 Schwartz,	 Burke,	
&	Cummings,	2014;	Ferguson,	Rodríguez-	Barraquer,	Dorigatti,	Mier-	y	
Teran-	Romero,	 &	 Laydon,	 2016).	 Epidemiological	 questions	 directed	










In	 the	 context	 of	 DENV,	 such	 approaches	 are	 now	 reaching	
the	 capacity	 to	 be	modulated	 and	 fitted	 to	 particular,	 existing	 host	
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populations	and	to	simulate	real-	world	scenarios	in	terms	of	transmis-
sion	 and	 control.	This	would	 be	 particularly	valuable	 in	 the	 context	
of	DENV	vaccination	modelling,	which	is	recent	in	the	literature	(e.g.,	
(Lourenço	 &	 Recker,	 2016;	 Flasche	 et	al.,	 2016;	 Chao	 et	al.,	 2012;	
Coudeville	&	Garnett,	2012)).	For	most	of	the	published	studies,	sim-
plifying	assumptions	are	made	on	population	heterogeneities	or	age-	






be	 considered.	 In	 summary,	 these	 advanced	 computing	 techniques	
have	the	capacity	to	change	our	perspective	of	modelling	frameworks	
from	being	based	on	groups,	 generally	of	 individuals	 sharing	 similar	
properties	or	phenotypes,	to	a	perspective	of	host-	pathogen	systems	
focusing	on	the	role	of	single	individuals,	and	how	the	mechanics	of	
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Brazilian	 data	 are	 for	 suspected	 case	 counts	 from	 the	 Sistema	 de	
Informação	 de	Agravos	 de	Notificação	 (national	 notifiable	 diseases	
information	system,	SINAN)	database	(Brazil	SINAN,	http://portalsi-
nan.saude.gov.br/).	The	regions	of	north	and	south,	as	presented	 in	
Figure	1,	 present	 aggregated	 data	 (south:	 states	 of	 Paraná,	 Santa	
Catarina,	 Rio	 Grande	 do	 Sul;	 north:	 states	 of	 Rondônia,	 Acre,	
Amazonas,	Roraima,	Pará,	Amapá,	Tocantins).
Dengue	incidence	data	for	Puerto	Rico	were	provided	by	Michael	
Johansson	 from	 the	CDC	Dengue	Branch,	 comprising	 clinically	 sus-
pected	 cases	of	 dengue	 fever	 (DF)	 and	dengue	haemorrhagic	 fever	
(DHF)	in	Puerto	Rico	between	1986	and	2012.	Serotype-	specific	test-
ing	has	varied	over	 time,	 so	we	adjusted	 the	 serotype-	specific	 inci-
dence	 data	 proportionally	 to	 match	 the	 incidence	 of	 all	 suspected	
cases	by	month.	A	shorter	time	series	had	previously	been	published	
and	analysed	in	(Johansson,	Cummings,	&	Glass,	2009).
Annual	 incidence	 of	 DHF	 in	 Thailand	 1973–2009	 is	 of	 clinically	
confirmed	cases	and	was	obtained	 from	 the	annual	 epidemiological	
surveillance	reports	published	by	the	Ministry	of	Public	Health	(web-




Yearly	 counts	 of	 dengue	 publications	 (1970–2016)	 were	 collected	
from	PubMed	under	two	lists	(queries).	The	first	contained	the	total	
number	of	publications	per	year	dedicated	to	dengue,	including	all	hits	
with	 reference	 to	dengue	 in	 the	 title	and	abstract	 (counts	collected	
using	the	“results	by	year”	functionality	in	PubMed).	The	second	was	
a	 subset	 of	 the	 first,	which	 included	 the	 use	 of	 dynamic	models	 in	
the	context	of	dengue	research	(manually	curated).	Queries	were	per-
formed	on	the	1st	of	February	2017.
